In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
|Podcasts|December 9, 2022
Achieving Success in the Rare Disease Space
Author(s)Nicholas Saraceno, Senior Editor
Lessons learned around commercializing new products in this niche sector
Advertisement
Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related to this article
In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, Walmart rolls out a $0 prescription tier and rare disease Center of Excellence for its US workforce and FDA launches its Rare Disease Framework Initiative.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Pharma Automation Cuts Human Touches and Error Risk
2
Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
3
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion
4
Supply Chain Signal: PhRMA’s GLOBE Lawsuit and the New Economics of Pharma Supply Chains
5